Aripiprazole versus brexpiprazole for people with schizophrenia

Abstract

Description

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the efficacy and tolerability of aripiprazole compared to brexpiprazole in people diagnosed with schizophrenia or schizophrenia‐like psychosis.

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By